Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis

Back

Delegates Premium Access

Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis

Session: Dyslipidaemia management in 2025: status quo and best practice (2)

Topic: Lipid-Lowering Agents

Speaker: Doctor V. Lanari (Milan, IT)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Doctor Valeria Chiara Lanari

Milan (Italy)

0 follower

5 more presentations in this session

Gender differences in the management of dyslipidemia in Switzerland

Speaker: Doctor R. de La Harpe (Lausanne, CH)

Access

Abstract

Slides

Prevalence and clinical relevance of familial hypercholesterolemia-causing mutations in Germany

Speaker: Doctor N. Arnold (Hamburg, DE)

Access

Abstract

Slides

More musculoskeletal disorders and poor pain management in patients with familial hypercholesterolemia and self-perceived side effects to cholesterol-lowering treatment

Speaker: Ms A. Uduma (Oslo, NO)

Access

Abstract

Slides

Monetary costs and LDL-C reduction from upfront combination lipid-lowering therapy with ezetimibe in an irish ACS cohort

Speaker: Doctor D. Butler (Galway, IE)

Access

Abstract

Slides

Evaluation of LDL levels and lipid optimisation in high cardiovascular risk patients in nurse-led clinics in Ireland: a cross-sectional study

Speaker: Mrs M. Brennan (Waterford, IE)

Access

Abstract

Slides

Access the full session

Dyslipidaemia management in 2025: status quo and best practice (2)

Speakers: Doctor V. Lanari, Doctor R. de La Harpe, Doctor N. Arnold, Ms A. Uduma, Doctor D. Butler...

Access

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources